EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.17.4.2 | triapine | a potent ribonucleotide reductase inhibitor, phase I and pharmacokinetic study in adults with advanced hematologic malignancies, detailed overview | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.17.4.2 | ribonucleoside triphosphate + thioredoxin | Homo sapiens | - |
2'-deoxyribonucleoside triphosphate + thioredoxin disulfide + H2O | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.17.4.2 | Homo sapiens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.17.4.2 | ribonucleoside triphosphate + thioredoxin | - |
Homo sapiens | 2'-deoxyribonucleoside triphosphate + thioredoxin disulfide + H2O | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
1.17.4.2 | tetramer | alpha2beta2 heterodimer with a regulatory, nucleotide binding site M1 subunit, and an inducible, catalytic M2 subunit which contains non-heme iron and a tyrosyl free radical, that are required for the enzymatic reduction of ribonucleotides | Homo sapiens |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.17.4.2 | ribonucleotide reductase | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.17.4.2 | thioredoxin | - |
Homo sapiens |